NaturalsceuticalsMart

09/01/2026

What is the story behind cross-border trade in technologies packaging between so-called Biowaste/Biodiesel utilities plants from free and paid municipal biowaste processing with twinned Phytopharm "biosafe plants" nearby with downstream drug mfging aimed at paying eventually infrastructural and operational costs for the other half of its story for seagrass fodder insider agri-retailing for surrounding dairy farms in semi-rural areas. The scene is already set for seed monies in the several CAD$M to construct the prototype plant whose parts can be discounted on purchase in trade of sale of the power utilities plant and Federal gov't funding available to initial HR training, R&D and commercialization here in Canada.

05/02/2026

Planning on dropping by to get our Audiocasts in USB stic form or packaging... ?
We are planning as we speak recordings on Nutraceuticals or new drugs that Skye Blue Corporation is interested in to gain monetary wealth for further investment with other future subsidiaries in the Agriculture and Health Life Sciences (our schema) with an intent to fuse both capabilities or capacities including making headway in R&D and commercialization in Enzyme Technology and in advancing with Genomics and Proteomics and Bioinformatics as in molecular design of biologics including biopharma, enzymes and monoclonal Abs (mAbs) as e. g. We'll call this subsidiary JLG Enterprises of Canada. Also, for that matter, a new development in protein-like polymers (PLPs) are emerging as biological drugs to suppress Nrf2 factor to treat or control both myocardial infarction (MI) and rheumatoid arthritis (RA) to be featured later on in more detail elsewhere and here. Meanwhile, see Jenovo Drug Chem Discovery Enterpises of Canada, for more details. As predicted stock or share offerings will be made for outside investors especially from the RP (Philippines) and Canada/USA/Mexico.

01/19/2026

We're still in the process of advancing our plans to publish the proprietary folio or folder on our starting material for synthetically manufacturing through bioengineering of E. coli hosts in bioreactor the ~32 step sequence for the orthopharma we dub active form VitD 2,3 agonist to help treat and prevent osteoporosis due to bone recalcification yet supporting Skye Blue's commitment to prevention therapeutic approaches in health & medicine with orthopharma, biopharma and nutracuetica.

Greetings to Kalamazoo College, our elite Michigander institution, and their Upjohn Library Commons area and our best wishes to send an update with version 2.0 for advancing research students wishing to further work in postgraduate surroundings, their advising professional practitioners and those also publishing at an earlier stage in their undergrad senior year with the ACS society, after completion of the Senior Integrated Project (SIP) experience before entering graduate school in the United States of America.

Email from SkyeBlueAssociation You don't want to miss this.     Join Us On TikTok. We pride ourselves on being a local Internet services provider located in the Port Coquitlam, British Columbia area.